Your browser doesn't support javascript.
loading
Challenges for the European governance of synthetic biology for human health.
Douglas, Conor Mw; Stemerding, Dirk.
Affiliation
  • Douglas CM; Technology Assessment, Rathenau Institute, The Hague, 2593 HW,, The Netherlands, conor.douglas@ubc.ca.
Life Sci Soc Policy ; 10: 6, 2014 Dec.
Article in En | MEDLINE | ID: mdl-26085442
Synthetic biology is a series of scientific and technological practices involved in the application of engineering principles to the design and production of predictable and robust biological systems. While policy discussions abound in this area, emerging technologies like synthetic biology present considerable challenges in the articulation of concrete policy options given that their introduction into society may still be in the distant future. This paper reports on a series of governance workshops that focused on synthetic biology's ethical, legal, and social implications (ELSI) as they pertain to human health, and discusses particular limitations of the ELSI approach that we encountered in our work. In an attempt to avoid policymaking for potential implications of uncertain future applications we instead conclude by proposing tangible forms of anticipatory governance that may be more adequate in addressing the more immediate concerns raised by synthetic biology.

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Ethics Language: En Journal: Life Sci Soc Policy Year: 2014 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Ethics Language: En Journal: Life Sci Soc Policy Year: 2014 Document type: Article Country of publication: United kingdom